Today: 20 May 2026
Ciena stock price swings on S&P 500 call-up, with Feb. 9 and March 5 in focus
5 February 2026
1 min read

Ciena stock price swings on S&P 500 call-up, with Feb. 9 and March 5 in focus

NEW YORK, February 5, 2026, 15:39 EST — Regular session

Ciena Corp shares slipped 0.8% to $251.41 Thursday afternoon, after fluctuating between $238.97 and $261.36 on roughly 2.7 million shares traded. S&P Dow Jones Indices announced Wednesday after the close that it will add the networking equipment maker to the S&P 500 ahead of trading on February 9. Ciena will replace Dayforce, following its acquisition by Thoma Bravo.

When an index adds a stock, funds that track that benchmark must buy in. This demand is automatic, but it still pushes prices up as investors race to front-run the rebalance, especially when liquidity dries up.

The timing couldn’t be more awkward as tech sentiment is already on edge. “Near-term earnings results will be important signals of business resilience,” noted Ben Snider, Goldman Sachs’ chief U.S. equity strategist, commenting on the wider selloff. Reuters

Ciena announced Thursday it plans to release fiscal first-quarter results on March 5 before the market opens, with management set to host a webcast at 8:30 a.m. Eastern. The company will also upload supporting materials to its investor relations site.

Ciena provides networking hardware and software that facilitate data movement across telecom and cloud networks. It goes head-to-head with bigger players like Cisco Systems and Nokia in segments of the transport and optical gear market.

A Form 4 filing revealed that CEO Gary B. Smith offloaded 2,952 shares at an average price of $265.6018. According to the filing, the sale occurred under a Rule 10b5-1 plan, which lets insiders set up predetermined trading schedules.

Index reshuffles don’t alter the fundamentals, and the boost from forced buying often fades quickly. Should the broader tech selloff intensify or Ciena’s March results fall short, the stock might lose any premium gained from being added to the index.

Focus now turns to the next tests: positioning ahead of Friday’s close and the opening on February 9, when benchmark funds usually make their adjustments. Then all eyes move to March 5, waiting on Ciena’s update on demand and margins.

Stock Market Today

  • Williams-Sonoma Gains 1.58% as Market Declines, Eyes Upcoming Earnings
    May 19, 2026, 7:31 PM EDT. Williams-Sonoma (WSM) shares rose 1.58% to $171.83, outperforming the S&P 500's 0.67% drop. The stock had declined 16.27% over the past month, lagging the sector's 0.69% loss but behind the S&P 500's 4% gain. Investors await WSM's upcoming earnings report, expected to show $1.80 per share in EPS, down 2.7% year-over-year, with revenue projected to rise 4.25% to $1.8 billion. The company's full-year estimates anticipate 4.75% EPS growth and 4.39% revenue growth. Analyst estimate revisions have nudged EPS projections higher by 0.58% in 30 days, with WSM holding a Zacks Rank #3 (Hold). Valuation indicators show a Forward P/E of 18.27, slightly below industry average, while the PEG ratio of 2.12 exceeds the Retail - Home Furnishings sector average of 1.63.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
S&P Global stock slides again as “Mobility Global” spin-off rebrand puts SPGI in the spotlight
Previous Story

S&P Global stock slides again as “Mobility Global” spin-off rebrand puts SPGI in the spotlight

AppLovin stock price slips after hours as CloudX launch and Wedbush target cut put Feb. 11 earnings in play
Next Story

AppLovin stock price slips after hours as CloudX launch and Wedbush target cut put Feb. 11 earnings in play

Go toTop